Skip to Content

IQ Healthy Hearts ETF HART

Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis HART

Will HART outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

IQ Healthy Hearts ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HART

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 50.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Alphabet Inc Class A

5.64 490,094
Communication Services

AstraZeneca PLC

5.56 483,334
Healthcare

Novo Nordisk A/S Class B

5.27 457,342
Healthcare

Eli Lilly and Co

4.94 429,291
Healthcare

Pfizer Inc

4.92 427,014
Healthcare

UnitedHealth Group Inc

4.84 420,493
Healthcare

Novartis AG Registered Shares

4.79 416,068
Healthcare

Johnson & Johnson

4.79 415,896
Healthcare

Apple Inc

4.72 410,122
Technology

Abbott Laboratories

4.66 404,618
Healthcare